<DOC>
	<DOCNO>NCT00040469</DOCNO>
	<brief_summary>The major goal study determine risk benefit bone marrow transplant patient severe thalassemia sickle cell disease . Participation project two year .</brief_summary>
	<brief_title>Bone Marrow Transplant From Related Donor Patients With High Risk Hemoglobinopathies</brief_title>
	<detailed_description>To bone marrow transplant , must first kill cell bone marrow make abnormal red blood cell find patient severe thalassemia sickle cell disease . We use three drug : busulfan , cyclophosphamide , CAMPATH-1H . CAMPATH-IH investigational drug . CAMPATH-1H use prevent participant reject refuse let donor blood cell grow body . After drug treatment , participant give bone marrow brother sister healthy bone marrow match .</detailed_description>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Hemoglobinopathies</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Phenytoin</mesh_term>
	<criteria>Inclusion : Patients homozygous B0/+ thalassemia severe variant B0/+ thalassemia HLA genotypically identical donor . Patients HLA genotype identical donor hemoglobin SS , hemoglobin SC , hemoglobin Sb 0/+ least one following : Previous central nervous system vasoocclusive episode without residual neurologic finding ; Frequent painful vasoocclusive episode significantly interfere normal life activity necessitate chronic transfusion therapy ; Recurrent SCD chest syndrome event necessitate chronic transfusion therapy . Severe anemia prevents acceptable quality life necessitates chronic transfusion therapy . The patient must HLA genotype identical donor . Between age birth 65 year . Women childbearing potential must negative pregnancy test . Exclusion : Biopsy proven chronic active hepatitis fibrosis portal bridging . SCD chronic lung disease &gt; /= stage 3 . Severe renal dysfunction define creatinine clearance &lt; 40 ml/min/1.73 M2 Severe cardiac dysfunction define shorten fraction &lt; 25 % . HIV infection . Severe unspecified chronic toxicity serious enough detrimentally affect patient 's capacity tolerate bone marrow transplant ( BMT ) . Inadequate intellectual capacity understand nature risk inherent BMT process give inform consent ( case minor , criterion must fulfil legal guardian ) . Pregnant , lactate unwilling use appropriate birth control .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>